Epitope based recombinant BCG vaccine elicits specific Th1 polarized immune responses in BALB/c mice

Vaccine

Volumn 30, Issue 7, 2012, Pages 1364-1370

  Christy, Aparna Josephine ^a   Dharman, Karthika ^a   Dhandapaani, Gayatri ^a   Palaniyandi, Kannan ^a   Gupta, Umesh D ^c   Gupta, Pushpa ^c   Ignacimuthu, S ^b   Narayanan, Sujatha ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b LOYOLA COLLEGE   (India)

^c National JALMA Institute For Leprosy and Other Mycabacterial Diseases   (India)

Author keywords

Epitope; Heat shock protein; Mycobacterium tuberculosis; Recombinant BCG; Vaccine

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; BCG VACCINE; CULTURE FILTRATE PROTEIN 10; EPITOPE; FBP PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; INV PROTEIN; MYCOBACTERIUM ANTIGEN; PPE68 PROTEIN; RECOMBINANT BCG VACCINE; RECOMBINANT VACCINE; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BCG VACCINATION; CELL PROLIFERATION; CELL SPECIFICITY; CELLULAR IMMUNITY; CHIMERA; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; GENE EXPRESSION; HUMORAL IMMUNITY; INJECTION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; SPLEEN CELL; TH1 CELL; TUBERCULOSIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BCG VACCINE; CYTOKINES; ELECTROPORATION; EPITOPES, T-LYMPHOCYTE; FEMALE; GUINEA PIGS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; PLASMIDS; SPLEEN; TH1 CELLS; TH1-TH2 BALANCE; TUBERCULOSIS, PULMONARY; VACCINES, ATTENUATED;

EID: 84856569744     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.059     Document Type: Article

References (38)

1. Kaufmann S.H. Envisioning future strategies for vaccination against tuberculosis. Nat Rev Immunol 2006, 6(September (9)):699-704.
2. Delogu G., Fadda G. The quest for a new vaccine against tuberculosis. J Infect Dev Ctries 2009, 3(1):5-15.
3. Rowland R., McShane H. Tuberculosis vaccines in clinical trials. Expert Rev Vaccines 2011, 10(May (5)):645-658.
4. Kaufmann S.H. How can immunology contribute to the control of tuberculosis?. Nat Rev Immunol 2001, 1(October (1)):20-30.
5. Hoft D.F. Tuberculosis vaccine development: goals, immunological design, and evaluation. Lancet 2008, 372(July (9633)):164-175.
6. Gao H., Yue Y., Hu L., Xu W., Xiong S. A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge. Vaccine 2009, 27(August (39)):5313-5319.
7. Rosa D.S., Ribeiro S.P., Cunha-Neto E. CD4+ T cell epitope discovery and rational vaccine design. Arch Immunol Ther Exp (Warsz) 2010, 58(April (2)):121-130.
8. Sette A., Fikes J. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Curr Opin Immunol 2003, 15(August (4)):461-470.
9. Sette A., Keogh E., Ishioka G., Sidney J., Tangri S., Livingston B., et al. Epitope identification and vaccine design for cancer immunotherapy. Curr Opin Investig Drugs 2002, 3(January (1)):132-139.
10. Sette A., Newman M., Livingston B., McKinney D., Sidney J., Ishioka G., et al. Optimizing vaccine design for cellular processing, MHC binding and TCR recognition. Tissue Antigens 2002, 59(June (6)):443-451.
11. Stover C.K., de la Cruz V.F., Fuerst T.R., Burlein J.E., Benson L.A., Bennett L.T., et al. New use of BCG for recombinant vaccines. Nature 1991, 351(June (6326)):456-460.
12. Dennehy M., Williamson A.L. Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines. Vaccine 2005, 23(January (10)):1209-1224.
13. Bastos R.G., Borsuk S., Seixas F.K., Dellagostin O.A. Recombinant Mycobacterium bovis BCG. Vaccine 2009, 27(November (47)):6495-6503.
14. Aravindhan V., Narayanan S., Gautham N., Prasad V., Kannan P., Jacobs W.R., et al. T-h-2 immunity and CD3+CD45RBlow-activated T cells in mice immunized with recombinant bacillus Calmette-Guerin expressing HIV-1 principal neutralizing determinant epitope. FEMS Immunol Med Microbiol 2006, 47(June (1)):45-55.
15. Matsuo K., Yamaguchi R., Yamazaki A., Tasaka H., Terasaka K., Totsuka M., et al. Establishment of a foreign antigen secretion system in mycobacteria. Infect Immun 1990, 58(December (12)):4049-4054.
16. Da Cruz F.W., McBride A.J., Conceicao F.R., Dale J.W., McFadden J., Dellagostin O.A. Expression of the B-cell and T-cell epitopes of the rabies virus nucleoprotein in Mycobacterium bovis BCG and induction of an humoral response in mice. Vaccine 2001, 20(December (5-6)):731-736.
17. Demangel C., Brodin P., Cockle P.J., Brosch R., Majlessi L., Leclerc C., et al. Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6. Infect Immun 2004, 72(April (4)):2170-2176.
18. Mitchison D.A., Wallace J.G., Bhatia A.L., Selkon J.B., Subbaiah T.V., Lancaster M.C. A comparison of the virulence in guinea-pigs of South Indian and British tubercle bacilli. Tubercle 1960, 41(February):1-22.
19. Mehra V., Bloom B.R., Bajardi A.C., Grisso C.L., Sieling P.A., Alland D., et al. A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. J Exp Med 1992, 175(January (1)):275-284.
20. Barnes P.F., Mehra V., Rivoire B., Fong S.J., Brennan P.J., Voegtline M.S., et al. Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis. J Immunol 1992, 148(March (6)):1835-1840.
21. Taneja B., Mande S.C. Structure of Mycobacterium tuberculosis chaperonin-10 at 3.5A resolution. Acta Crystallogr D Biol Crystallogr 2002, 58(February (Pt 2)):260-266.
22. Pym A.S., Brodin P., Brosch R., Huerre M., Cole S.T. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol 2002, 46(November (3)):709-717.
23. Lewis K.N., Liao R., Guinn K.M., Hickey M.J., Smith S., Behr M.A., et al. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation. J Infect Dis 2003, 187(January (1)):117-123.
24. Pym A.S., Brodin P., Majlessi L., Brosch R., Demangel C., Williams A., et al. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 2003, 9(May (5)):533-539.
25. Arend S.M., Geluk A., van Meijgaarden K.E., van Dissel J.T., Theisen M., Andersen P., et al. Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect Immun 2000, 68(June (6)):3314-3321.
26. Lalvani A., Nagvenkar P., Udwadia Z., Pathan A.A., Wilkinson K.A., Shastri J.S., et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 2001, 183(February (3)):469-477.
27. Belisle J.T., Vissa V.D., Sievert T., Takayama K., Brennan P.J., Besra G.S. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 1997, 276(May (5317)):1420-1422.
28. Wiker H.G., Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 1992, 56(December (4)):648-661.
29. Jackson M., Raynaud C., Laneelle M.A., Guilhot C., Laurent-Winter C., Ensergueix D., et al. Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope. Mol Microbiol 1999, 31(March (5)):1573-1587.
30. Puech V., Guilhot C., Perez E., Tropis M., Armitige L.Y., Gicquel B., et al. Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of Mycobacterium tuberculosis. Mol Microbiol 2002, 44(May (4)):1109-1122.
31. D'Souza S., Rosseels V., Romano M., Tanghe A., Denis O., Jurion F., et al. Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis. Infect Immun 2003, 71(January (1)):483-493.
32. Lee B.Y., Horwitz M.A. T-cell epitope mapping of the three most abundant extracellular proteins of Mycobacterium tuberculosis in outbred guinea pigs. Infect Immun 1999, 67(May (5)):2665-2670.
33. Silver R.F., Wallis R.S., Ellner J.J. Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Guerin in purified protein derivative (PPD)-positive individuals. J Immunol 1995, 154(May (9)):4665-4674.
34. Jain R., Dey B., Dhar N., Rao V., Singh R., Gupta U.D., et al. Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung. PLoS One 2008, 3(12):e3869.
35. Gao L.Y., Pak M., Kish R., Kajihara K., Brown E.J. A mycobacterial operon essential for virulence in vivo and invasion and intracellular persistence in macrophages. Infect Immun 2006, 74(March (3)):1757-1767.
36. Wangoo A., Sparer T., Brown I.N., Snewin V.A., Janssen R., Thole J., et al. Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease. J Immunol 2001, 166(March (5)):3432-3439.
37. Finkelman F.D., Holmes J., Katona I.M., Urban J.F., Beckmann M.P., Park L.S., et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990, 8:303-333.
38. Hovav A.H., Mullerad J., Davidovitch L., Fishman Y., Bigi F., Cataldi A., et al. The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection. Infect Immun 2003, 71(June (6)):3146-3154.